Avidity Partners Management LP - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 49 filers reported holding AC IMMUNE SA in Q4 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Avidity Partners Management LP ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2023$8,463,930
-1.3%
2,969,800
+2.3%
0.34%
+13.7%
Q2 2023$8,579,187
+1026.7%
2,903,278
+792.2%
0.30%
+1100.0%
Q1 2023$761,436
+14.7%
325,4000.0%0.02%
+78.6%
Q4 2022$663,816
-23.6%
325,400
+18.4%
0.01%
-22.2%
Q3 2022$869,000
-92.6%
274,876
-84.2%
0.02%
-93.1%
Q3 2021$11,673,000
-7.1%
1,739,600
+9.8%
0.26%
-23.8%
Q2 2021$12,561,000
+66.1%
1,584,000
+2.2%
0.34%
-3.1%
Q3 2020$7,564,0001,550,0000.35%
Other shareholders
AC IMMUNE SA shareholders Q4 2021
NameSharesValueWeighting ↓
Duquesne Family Office 1,500,000$24,705,0002.18%
Monashee Investment Management LLC 275,000$4,529,0001.59%
SPHERA FUNDS MANAGEMENT LTD. 79,800$1,314,0000.21%
Hillhouse Capital Management 550,000$9,059,0000.18%
Temasek Holdings (Private) Ltd 1,337,500$22,029,0000.18%
PointState Capital LP 425,000$7,000,0000.07%
Artal Group S.A. 150,000$2,471,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 87,900$1,448,0000.04%
Schonfeld Strategic Advisors LLC 14,779$243,0000.04%
Point72 Hong Kong Ltd 4,000$66,0000.04%
View complete list of AC IMMUNE SA shareholders